Pharma Pulse 5/2/24: The Impact of IRA on Drug Prices and Patient Access, Early Communication Crucial for Successful Drug Launch & more


The latest news for pharma industry insiders.

Why Early Communication is Crucial for a Successful Drug Launch

In this Pharmaceutical Executive video interview, Chris Martin, Chief Commercial Officer, Verona Pharma, discusses specific advantages for a small biotech company in crafting a unique commercialization strategy and the importance of starting early and getting aligned.

Expert Breaks Down Impact of IRA on Drug Prices and Patient Access

Sarah Butler, chief commercial officer at ADVI Health, discusses the substantial impact that the Inflation Reduction Act will have on drug prices and patient access to medications. She explains how some negotiated drug prices under the new law may end up higher than current out-of-pocket costs for patients.

Senators Slam UnitedHealth’s CEO Over Cyberattack

Several lawmakers questioned whether the company had become so large — with tentacles in every aspect of the nation’s medical care — that the effects of the hack were outsize.

Paralympic Gold Medalist Creates Custom Prosthetics for Athletes through Protolabs' Digital Manufacturing Service

Protolabs highlights its critical work with BioDapt, a company that designs, manufactures, and distributes high-performance lower limb prosthetic equipment used for action sports and other activities with similar physical demands.

@WebMD on Twitter/X:

There is some evidence that vitamin D levels could have an effect on diabetes (types 1 and 2) high blood pressure, multiple sclerosis, and some types of cancer. What to know about vitamin D:

Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor Miranda Schmalfuhs

© 2024 MJH Life Sciences

All rights reserved.